P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY - NEURODEVELOPMENT AND SCHIZOPHRENIA

被引:95
|
作者
PETTEGREW, JW
KESHAVAN, MS
MINSHEW, NJ
机构
[1] UNIV PITTSBURGH, SCH MED, WESTERN PSYCHIAT INST & CLIN, DEPT PSYCHIAT, PITTSBURGH, PA 15261 USA
[2] UNIV PITTSBURGH, SCH MED,WESTERN PSYCHIAT INST & CLIN, DEPT PSYCHIAT,CTR MEMBRANE STUDIES, PITTSBURGH, PA 15261 USA
关键词
D O I
10.1093/schbul/19.1.35
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
A number of studies have demonstrated alterations in the structure and function of the frontolimbic system in some schizophrenic patients. Recent in vivo phosphorus-31 nuclear magnetic resonance studies of the dorsal prefrontal cortex in neuroleptic-naive, first-episode schizophrenic patients and matched controls have shown evidence of alterations in membrane phospholipid and energy metabolism. The membrane alterations observed in the schizophrenic patients are compatible with either premature aging or altered timing and exaggeration of regressive events occurring during normal brain development. These molecular changes may precede onset of clinical symptoms and brain structural changes in schizophrenia and suggest fresh approaches to the pathogenesis and treatment of this illness.
引用
收藏
页码:35 / 53
页数:19
相关论文
共 50 条
  • [1] P-31 NUCLEAR-MAGNETIC-RESONANCE OF PHOSPHOPROTEINS
    VOGEL, HJ
    [J]. METHODS IN ENZYMOLOGY, 1989, 177 : 263 - 282
  • [2] P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY IN THE HUMAN NEONATAL BRAIN
    DELIVORIAPAPADOPOULOS, M
    DIGIACOMO, JE
    [J]. SEMINARS IN PERINATOLOGY, 1990, 14 (03) : 248 - 257
  • [3] MEDICAL APPLICATIONS OF P-31 NUCLEAR-MAGNETIC-RESONANCE
    SEELIG, J
    [J]. PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1987, 30 (3-4): : 593 - 595
  • [4] P-31 NUCLEAR-MAGNETIC-RESONANCE STUDIES IN DEMENTIA
    MIATTO, O
    GONZALEZ, G
    BUONANNO, FS
    BLUMBERG, H
    SELKOE, DJ
    GROWDON, JH
    [J]. NEUROLOGY, 1986, 36 (04) : 105 - 105
  • [5] MENINGIOMA PHOSPHOLIPID PROFILES MEASURED BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY
    SEIJO, L
    MERCHANT, TE
    VANDERVEN, LTM
    MINSKY, BD
    GLONEK, T
    [J]. LIPIDS, 1994, 29 (05) : 359 - 364
  • [6] P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY STUDY OF THE ANAEROBIC THRESHOLD IN HUMANS
    SYSTROM, DM
    KANAREK, DJ
    KOHLER, SJ
    KAZEMI, H
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1990, 68 (05) : 2060 - 2066
  • [7] MYOADENYLATE DEAMINASE DEFICIENCY - P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY INVESTIGATION
    GROSS, B
    GLASBERG, MR
    KENSORA, TG
    EGGERAAT, S
    SMITH, MB
    WELCH, KMA
    [J]. ANNALS OF NEUROLOGY, 1987, 22 (01) : 128 - 129
  • [8] REVERSIBLE ALTERATIONS IN P-31 NUCLEAR-MAGNETIC-RESONANCE (P-31 NMR) SPECTROSCOPY OF BRAIN DURING ISCHEMIA
    LAPTOOK, AR
    CORBETT, RJT
    NUNNALLY, RL
    [J]. PEDIATRIC RESEARCH, 1986, 20 (04) : A463 - A463
  • [9] CEREBRAL METABOLISM IN HYPOXIA AND HYPERCAPNIA BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY
    BARRERE, B
    MERIC, P
    PERES, M
    BELOEIL, JC
    BERENGER, G
    LALLEMAND, JY
    SEYLAZ, J
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1987, 67 (02): : P27 - P28
  • [10] P-31 magnetic resonance spectroscopy studies in schizophrenia
    Williamson, PC
    Brauer, M
    Leonard, S
    Thompson, T
    Drost, D
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1996, 55 (1-2): : 115 - 118